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PROBLEM IDENTIFICATION AND NEED
 Due to state legalization and increased access to cannabis, 
there is increasing use nationwide
 Cannabis is used medically for certain qualifying conditions in 
Vermont in addition to recreationally [1]
 45% of adult primary care patients in Vermont had used 
cannabis in the last year [2]
 Only 18% of patients reported their clinician as being a good 
source of information regarding cannabis. [2]
 Educating clinicians about cannabis is critical for quality 
comprehensive patient care
PUBLIC HEALTH COST AND UNIQUE COST CONSIDERATIONS
 Over 25 million adults in the US have had pain for the last 3 
months and about 40 million adults had severe pain. [3]
 Patients with pain were correlated with decreased health 
outcomes, increased utilization of healthcare [3]
 The cost of pain in the United States is approximated to be 
$635 billion annually [3]
 Misuse of opioids and other prescription narcotics is a 
serious public health crisis in Vermont
 111 people died in 2019 in Vermont on accident from 
opioids [4]
 49,497morphine milligram equivalents (MMEs) were 
distributed (per 100 citizens) in Vermont in 2019 [4]
 Currently, there are 4341 patients enrolled in the Vermont 
Marijuana Registry
COMMUNITY PERSPECTIVE
Lindsey Wells, Marijuana Program Administrator, Department of Public Safety
 Barriers to patients accessing medical marijuana: “…the $50 fee, the cumbersome application, and locating a health professional for verification 
are barriers. I have heard from the dispensaries well over half the patients they serve have a gross household income equal to or less than 185% 
of the Federal Poverty Level.”
 Dispensary employees don’t need official education or certification. They need to pass a fingerprint and supported background check. 
Ada Puches, Community Educator, Southern Vermont Wellness
 “A huge target audience of my outreach is indeed healthcare providers in the state. I have presented to hospital departments, clinics, private providers, 
and healthcare associations. Additionally, I attend a variety of health conferences as an exhibitor for our company. I also attempt to educate as many 
patients and members of the public as possible through patient conferences, community groups, patient support groups, non-profits and public 
lectures at libraries and civic organizations.”
 ”Despite its safety profile - many primary care physicians STILL feel uncomfortable or won’t sign a verification form for an eligible patient.”
 “Since every patient’s endocannabinoid system is different - patients must do a trial and error process as to strain, formulation, method of 
consumption, etc. Overall, it works out quite well for patients. Dispensary personnel are knowledgeable, warm and welcoming and patients are made to 
feel that we understand their symptoms. Indeed, sometimes the ONLY symptom relief patients feel is from cannabis consumption.”
 “Medical cannabis should absolutely be de-scheduled. We now know that it has many, many medical/therapeutic applications (Dravet syndrome). The 
combination of its safety profile and prolific therapeutic applications makes it’s removal as a controlled substance long overdue.”
INTERVENTION AND METHODOLOGY 
 One study has found that over half of providers surveyed did not 
want to address patient’s questions about cannabis and wanted 
to learn more [5]
 Develop a short survey to deploy to primary care clinicians 
throughout the state to get a baseline assessment of their 
medical understanding of cannabis
 No verified knowledge assessment of medical cannabis to date
 Curated from The Vermont Academic Detailing, and Substance abuse and 
mental health services [6]
 Could be used as a pre and post assessment after intervention
 Identify and understand the knowledge base of cannabis of 
primary care providers in order to deliver education and 
resources that they could provide to patients
RESULTS/RESPONSE 
 Spoke to various patients at Deerfield Southern Vermont Medical Center 
office who expressed using cannabis and they said they wished they could 
ask their physicians more questions about cannabis and were enthusiastic 
about receiving reliable resources to do their own research
 A physician at the practice felt that cannabis needs to be de-scheduled to 
have quality research be done in order to provide reliable information to 
patients and is open to learning more about medicinal cannabis
 Hopefully, with the deployment of the survey it influences providers to 
research cannabis, participate in learning opportunities regarding cannabis, 
and begin to collect resources to provide patients with
EVALUATION OF EFFECTIVENESS AND LIMITATIONS 
 Evaluation of Effectiveness:
 Use survey as pre and post assessment
 Evaluate response of clinician attendance to learning sessions, conferences, etc.
 Interview patients' feelings of provider’s knowledge 
 Recognize what practices have resources to provide patients and their staff about 
cannabis
 Limitations:
 Short duration of time
 No verified surveys 
 Without verified survey data it is challenging to know what value a novel survey has
 All physicians may not be able to educate or attend academic detailing sessions on 
cannabis
 Only one medical center location
RECOMMENDATIONS FOR FUTURE INTERVENTIONS/PROJECTS
 Survey could be improved and refined 
 Survey can be given to other states
 Survey could be given to other medical specialties 
outside primary care (ex/ oncology, neurology, etc.) 
 Information dissemination to practices and clinicians 
(academic detailing, cannabinoid clinic in Burlington, 
conferences, CME courses) 
 Create dot phrase with reliable resources for 
patients 
 More standardization of screening of cannabis use 
and EMR integration 
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 Thank you for agreeing to be interviewed. This project is a requirement for the Family Medicine clerkship. It will be stored on the Dana Library 
ScholarWorks website. Your name will be attached to your interview and you may be cited directly or indirectly in subsequent unpublished or 
published work. The interviewer affirms that he/she has explained the nature and purpose of this project. The interviewee affirms that 
he/she has consented to this interview. 
 Consented 
 Lindsey Wells, Marijuana Program Administrator, Department of Public Safety
 Ada Puches, Community Educator, Southern Vermont Wellness
 Did NOT Consent
 Name: ______________________________________________________________ 
 Name: ______________________________________________________________
